Is it safe to take aspirin concurrently with cilostazol?

Can You Take Aspirin in Addition to Cilostazol?

In most clinical contexts, aspirin should NOT be routinely combined with cilostazol, as guidelines recommend against adding cilostazol to standard dual antiplatelet therapy (aspirin plus clopidogrel) after coronary stenting. 1

Context-Specific Recommendations

For Patients with Coronary Stents (Post-PCI)

The American College of Chest Physicians guidelines explicitly state:

• Do NOT add cilostazol to aspirin plus clopidogrel (Grade 1B recommendation) 1
• Aspirin and clopidogrel dual therapy is preferred over any regimen involving cilostazol
• Cilostazol should only be used as a substitute (not an addition) when you have an allergy or intolerance to either aspirin or clopidogrel (Grade 2C) 1

This recommendation prioritizes mortality and morbidity outcomes, as triple antiplatelet therapy increases bleeding risk without proven cardiovascular benefit. Recent meta-analysis confirms that cilostazol-based triple therapy increases adverse events (headache, palpitations) and in-hospital mortality compared to standard dual therapy 2.

For Peripheral Artery Disease (PAD)

The situation differs for PAD patients:

• Single antiplatelet therapy is standard after the initial post-revascularization period 3
• Cilostazol 100 mg twice daily is an acceptable alternative to aspirin or clopidogrel for long-term secondary prevention in symptomatic PAD 4
• The 2024 ACC/AHA PAD guidelines list cilostazol as an option for single antiplatelet therapy but do not recommend routine combination with aspirin 3

For Stroke/TIA Prevention

For noncardioembolic stroke:

• Cilostazol monotherapy (100 mg twice daily) is recommended as an alternative to aspirin or clopidogrel 4
• Recent evidence shows aspirin plus cilostazol increases intracranial hemorrhage risk (HR 1.82,95% CI 1.16-2.84) compared to aspirin plus clopidogrel 5
• Short-term dual therapy (aspirin plus cilostazol) for acute stroke showed no efficacy benefit over aspirin alone 6

However, emerging data from East Asian populations suggests cilostazol-based dual therapy may reduce ischemic stroke recurrence in long-term (>3 months) prevention, though with increased general adverse events 7.

Safety Profile of Combination Therapy

When aspirin and cilostazol are combined:

• No increase in bleeding time, PT, or aPTT in pharmacokinetic studies 8
• 23-35% increase in platelet aggregation inhibition compared to aspirin alone 8
• Higher rates of headache and palpitations due to cilostazol's vasodilatory effects 2
• Increased intracranial hemorrhage risk in stroke patients 5

Clinical Algorithm

Use this decision tree:

1. Post-PCI with stent?

   • Use aspirin + clopidogrel (NOT cilostazol)
   • Only substitute cilostazol if aspirin/clopidogrel intolerance exists 1

2. Symptomatic PAD (claudication)?

   • Use single agent: aspirin, clopidogrel, OR cilostazol
   • Do not routinely combine 3

3. Stroke/TIA prevention?

   • Use single agent: aspirin, clopidogrel, OR cilostazol
   • Avoid aspirin + cilostazol due to increased ICH risk 5

4. Aspirin intolerance after PCI?

   • Cilostazol + clopidogrel is acceptable 9

Critical Caveats

• Drug interactions: Strong CYP3A4 inhibitors (ketoconazole, itraconazole, fluconazole) increase cilostazol levels by 94-117%; reduce cilostazol dose to 50 mg twice daily 10
• Contraindications: Cilostazol is contraindicated in heart failure patients (not mentioned in your question but critical for safety)
• Monitoring: Patients on aspirin + cilostazol require careful monitoring for bleeding complications, particularly intracranial hemorrhage 5

The evidence strongly favors using cilostazol as an alternative to—not in addition to—aspirin in most clinical scenarios, with the primary exception being specific cases of drug intolerance where substitution is necessary.